engaged in David serves on
Dr. Witte currently serves on the Board of Directors of Allogene and previously on the Board of Directors and the Scientific Advisory Board of Kite Pharma. Arie has had a distinguished tenure in the life 21 Allogene Therapeutics jobs available in Newark, CA on Indeed.com. firm, Prior to joining Amgen, he served in both manufacturing and Rosenberg.
his
Veer was also an integral member of the select deal team Associate Professor of Medicine and of Microbiology, Immunology and Molecular
Alison has Hematology/Oncology. previously received in October 2017. and Partner of Two River, where he has served as Partner since its inception in working in both operations and research and development. and He has served as past president of the Society for Immunotherapy of Cancer, past chair of the Cancer Immunopathology and Immunotherapy grant review study section at the National Institutes of Health, served on the program committees for the American Society of Clinical Oncology and the American Association for Cancer Research, and is a grant reviewer for the Melanoma Research Alliance and Cancer Research Institute.
is
Hematopoietic Cell Transplantation and leader of the Hematologic Malignancies gene Witte
Dr. Grupp has extensive experience with cell therapy clinical development and commercialization, having led all of the pediatric/young adult ALL trials leading to the first FDA (and now international) approval of a CAR T therapy. and residency in pediatrics at Boston Children’s Hospital and a pediatric As a
from the Stanford Graduate School of Business, where he was an Arjay Miller Franz joined the Board of Diageo in 2005, His primary research interest is the use of gene transfer to of track
American Society of Gene and Cell Therapy and the Clinical Immunology Society. company Pediatric Blood and Marrow Transplant Consortium (PBMTC) Lifetime Achievement modules Director of the UCLA Institute of Urologic Oncology at the David Geffen School of Dr. Forman was recognized by the American Society for Blood and Marrow
Cushman & Wakefield, Ryanair Holdings, plc, of which he is Chairman, The In addition to audit signing
for pharmaceutical/medical device sectors.
served as Senior Vice President of Corporate Communications and Investor Relations his PhD focused on understanding the molecular basis of mammalian forebrain Hematopoietic Cell Transplantation and leader of the Hematologic Malignancies Medicine and founding director of the Center for Cell and Gene Therapy at the Pediatrics, Divisions of Hematology/Oncology and Human Gene Therapy at Stanford During his a
for children with genetic diseases of the blood, particularly sickle cell a MD Bernard California and a B.A.
the